The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bernhardt, 2006, Cytochromes P450 as versatile biocatalysts, J. Biotechnol., 124, 128, 10.1016/j.jbiotec.2006.01.026
Guengerich, 2002, Cytochrome P450 enzymes in the generation of commercial products, Nat. Rev. Drug Discov., 1, 359, 10.1038/nrd792
Kubo, 2006, Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450 BM-3, Chemistry, 12, 1216, 10.1002/chem.200500584
van Vugt-Lussenburg, 2006, Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3, Biochem. Biophys. Res. Commun., 346, 810, 10.1016/j.bbrc.2006.05.179
Lussenburg, 2005, Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants, Anal. Biochem., 341, 148, 10.1016/j.ab.2005.02.025
Munro, 2002, P450 BM3: the very model of a modern flavocytochrome, Trends Biochem. Sci., 27, 250, 10.1016/S0968-0004(02)02086-8
Eiben, 2006, Preparative use of isolated CYP102 monooxygenases: a critical appraisal, J. Biotechnol., 124, 662, 10.1016/j.jbiotec.2006.02.013
Hollmann, 2006, Non-enzymatic regeneration of nicotinamide and flavin cofactors for monooxygenase catalysis, Trends Biotechnol., 24, 163, 10.1016/j.tibtech.2006.02.003
Urlacher, 2006, Cytochrome P450 monooxygenases: perspectives for synthetic application, Trends Biotechnol., 24, 324, 10.1016/j.tibtech.2006.05.002
Di Nardo, 2007, Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes, J. Biol. Inorg. Chem., 12, 313, 10.1007/s00775-006-0188-4
Jiang, 2006, Radical intermediates in the catalytic oxidation of hydrocarbons by bacterial and human cytochrome P450 enzymes, Biochemistry, 45, 533, 10.1021/bi051840z
Otey, 2006, Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450, Biotechnol. Bioeng., 93, 494, 10.1002/bit.20744
Vugt-Lussenburg, 2007, Identification of critical residues in novel drug-metabolizing mutants of cytochrome P450 BM3 using random mutagenesis, J. Med. Chem., 50, 455, 10.1021/jm0609061
Landwehr, 2006, Enantioselective α-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3, J. Am. Chem. Soc., 128, 6058, 10.1021/ja061261x
Otey, 2004, Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach, Chem. Biol., 11, 309, 10.1016/j.chembiol.2004.02.018
Guengerich, 2001, Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity, Chem. Res. Toxicol., 14, 611, 10.1021/tx0002583
Peters, 2003, Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3, J. Am. Chem. Soc., 125, 13442, 10.1021/ja0303790
Vail, 2005, Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli, J. Ind. Microbiol. Biotechnol., 32, 67, 10.1007/s10295-004-0202-1
Rushmore, 2000, Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites, Metab. Eng., 2, 115, 10.1006/mben.2000.0147
Schaefer, 1985, Characterization of the enzymatic and nonenzymatic peroxidative degradation of iron porphyrins and cytochrome P-450 heme, Biochemistry, 24, 3254, 10.1021/bi00334a027
Zhu, 2005, Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes, Drug Metab. Dispos., 33, 500, 10.1124/dmd.104.000836
Kim, 2005, Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis, J. Biol. Chem., 280, 40319, 10.1074/jbc.M508171200
Urlacher, 2006, Recent advances in oxygenase-catalyzed biotransformations, Curr. Opin. Chem. Biol., 10, 156, 10.1016/j.cbpa.2006.02.001
Rui, 2005, Protein engineering of toluene ortho-monooxygenase of Burkholderia cepacia G4 for regiospecific hydroxylation of indole to form various indigoid compounds, Appl. Microbiol. Biotechnol., 66, 422, 10.1007/s00253-004-1698-z
Szewczyk, 2003, Application of microscopic fungi isolated from polluted industrial areas for polycyclic aromatic hydrocarbons and pentachlorophenol reduction, Biodegradation, 14, 1, 10.1023/A:1023522828660
Berry, 2002, Application of metabolic engineering to improve both the production and use of biotech indigo, J. Ind. Microbiol. Biotechnol., 28, 127, 10.1038/sj.jim.7000228
Harford-Cross, 2000, Protein engineering of cytochrome p450(cam) (CYP101) for the oxidation of polycyclic aromatic hydrocarbons, Protein Eng., 13, 121, 10.1093/protein/13.2.121
Ost, 2000, Rational re-design of the substrate-binding site of flavocytochrome P450 BM3, FEBS Lett., 486, 173, 10.1016/S0014-5793(00)02267-5
Li, 2001, Rational evolution of a medium chain-specific cytochrome P450 BM-3 variant, Biochim. Biophys. Acta, 1545, 114, 10.1016/S0167-4838(00)00268-5
Gilardi, 2002, Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology, Biosens. Bioelectron., 17, 133, 10.1016/S0956-5663(01)00286-X
Park, 2006, Design and evolution of new catalytic activity with an existing protein scaffold, Science, 311, 535, 10.1126/science.1118953
Guerois, 2002, Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations, J. Mol. Biol., 320, 369, 10.1016/S0022-2836(02)00442-4
Wernerus, 2004, Biotechnological applications for surface-engineered bacteria, Biotechnol. Appl. Biochem., 40, 209, 10.1042/BA20040014
Li, 1997, The structure of the cytochrome P450 BM-3 haem domain complexed with the fatty acid substrate palmitoleic acid, Nat. Struct. Biol., 4, 140, 10.1038/nsb0297-140
Ravichandran, 1993, Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s, Science, 261, 731, 10.1126/science.8342039
Alcalde, 2004, Colorimetric high-throughput assay for alkene epoxidation catalyzed by cytochrome P450 BM-3 variant, J. Biomol. Screen., 9, 141, 10.1177/1087057103261913
Li, 2000, Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst, Chemistry, 6, 1531, 10.1002/(SICI)1521-3765(20000502)6:9<1531::AID-CHEM1531>3.3.CO;2-4
Li, 2001, Engineering cytochrome P450 BM-3 for oxidation of polycyclic aromatic hydrocarbons, Appl. Environ. Microbiol., 67, 5735, 10.1128/AEM.67.12.5735-5739.2001
Sulistyaningdyah, 2004, Metabolism of polychlorinated dibenzo-p-dioxins by cytochrome P450 BM-3 and its mutant, Biotechnol. Lett., 26, 1857, 10.1007/s10529-004-5317-y
Urlacher, 2002, Biotransformations using prokaryotic P450 monooxygenases, Curr. Opin. Biotechnol., 13, 557, 10.1016/S0958-1669(02)00357-9
Yamazaki, 1996, Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes, Biochem. Pharmacol., 52, 301, 10.1016/0006-2952(96)00208-0
Spatzenegger, 2003, Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling, J. Pharmacol. Exp. Ther., 304, 477, 10.1124/jpet.102.043323
Hiroi, 2002, Catalytic specificity of CYP2D isoforms in rat and human, Drug Metab. Dispos., 30, 970, 10.1124/dmd.30.9.970
Li, 2002, Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high-affinity and -turnover enzyme-specific probe substrate, J. Pharmacol. Exp. Ther., 300, 399, 10.1124/jpet.300.2.399
Lussenburg, 2005, The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent, Biochem. Pharmacol., 70, 1253, 10.1016/j.bcp.2005.07.002
Gao, 2006, Identification of the interactions between cytochrome P450 2E1 and cytochrome b5 by mass spectrometry and site-directed mutagenesis, J. Biol. Chem., 281, 20404, 10.1074/jbc.M601785200
Thummel, 1993, Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4, Biochem. Pharmacol., 45, 1563, 10.1016/0006-2952(93)90295-8
Keizers, 2005, Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation, J. Med. Chem., 48, 6117, 10.1021/jm050338+
Asikainen, 2003, Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes, Toxicol. In Vitro, 17, 449, 10.1016/S0887-2333(03)00065-1
Estavillo, 2003, Epoxidation of styrene by human cyt P450 1A2 by thin film electrolysis and peroxide activation compared to solution reactions, Biophys. Chem., 104, 291, 10.1016/S0301-4622(02)00383-6
Nakajima, 1994, Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450, Chem. Res. Toxicol., 7, 891, 10.1021/tx00042a026
Chiappe, 1998, Stereochemistry of the biotransformation of 1-hexene and 2-methyl-1-hexene with rat liver microsomes and purified P450s of rats and humans, Chem. Res. Toxicol., 11, 1487, 10.1021/tx980170d